Prognostic value of nutritional and functional screening instruments for mortality in patients with hematologic malignancies
Authors:
- Taise Andrade da AnunciaçãoTATaise Andrade da Anunciação
- Anna Karla Carneiro RorizARAnna Karla Carneiro Roriz
- Tícia Ranessa Santos CamposTCTícia Ranessa Santos Campos
- Luana Milen VarjãoLVLuana Milen Varjão
- Catarina Lobo Santos de SouzaCSCatarina Lobo Santos de Souza
- Ramona Souza da Silva Baqueiro BoulhosaRBRamona Souza da Silva Baqueiro Boulhosa
- Pricilla de Almeida MoreiraPMPricilla de Almeida Moreira
- Lilian Barbosa RamosLRLilian Barbosa Ramos
- Marco Aurélio Salvino de AraújoMAMarco Aurélio Salvino de Araújo
Open Access
- 1 May 2026
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (5) , 484
Abstract
Purpose: Functional and nutritional impairments adversely affect outcomes in hematologic malignancies; however, the comparative prognostic value of widely available screening instruments remains insufficiently explored. The present study aimed to examine the association between nutritional and functional screening instruments and 12-month mortality in hospitalized patients with hematologic malignancies. Methods: In this prospective cohort of 91 patients (median age 53 years [IQR, 35–61]), nutritional screening and assessment tools (PG-SGA, GLIM criteria) and functional screening instruments (SARC-F, SARC-CalF, and Geriatric 8 [G8]) were applied within 72 h of admission. The G8 was pragmatically used as a multidimensional vulnerability screening instrument. Discriminative ability for mortality was evaluated using ROC curve analysis, and Cox regression models (unadjusted and adjusted) were used to examine associations with mortality. Results: During follow-up, 29.7% of patients died. The G8 and SARC-CalF were associated with mortality in adjusted models (HR 4.83, 95% CI 1.13–20.68; HR 2.37, 95% CI 1.08–5.17, respectively). PG-SGA Global showed acceptable discriminative performance in ROC analyses (AUC 0.71) but was not associated with mortality after adjustment. GLIM criteria were not associated with mortality in adjusted models. Conclusion: The G8 and SARC-CalF scores have demonstrated prognostic utility as simple and low-cost screening tools associated with mortality in these patients with hematological malignancies hospitalized in a resource-limited service.Keywords
This publication has 40 references indexed in Scilit:
- Comparing SARC-F with SARC-CalF for screening sarcopenia in advanced cancer patientsClinical Nutrition, 2020
- Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancerGynecologic Oncology, 2020
- Sarcopenia: A Time for Action. An SCWD Position PaperJournal of Cachexia, Sarcopenia and Muscle, 2019
- The effect of malnutrition on mortality in hospitalized patients with hematologic malignancySupportive Care in Cancer, 2019
- Sarcopenia: revised European consensus on definition and diagnosisAge and Ageing, 2018
- Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric OncologyJournal of Clinical Oncology, 2018
- Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncologyCA: A Cancer Journal for Clinicians, 2017
- Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical PracticeJournal of the American Medical Directors Association, 2016
- Screening older cancer patients: first evaluation of the G-8 geriatric screening toolAnnals of Oncology, 2012
- The Inconsistency of “Optimal” Cutpoints Obtained using Two Criteria based on the Receiver Operating Characteristic CurveAmerican Journal of Epidemiology, 2006